US challenges 'bogus' patents on Ozempic and other drugs in effort to spur competition
Release time：2024-05-21 17:43:31 Source：International Index news portal
WASHINGTON (AP) — Federal regulators are challenging patents on 20 brand name drugs, including the blockbuster weight-loss injection Ozempic, in the latest action by the Biden administration targeting industry practices that drive up pharmaceutical prices.
The Federal Trade Commission on Tuesday sent warning letters to 10 drugmakers, taking issue with patents on popular drugs for weight loss, diabetes, asthma and other reparatory conditions. The letters allege that certain patents filed by Novo Nordisk, GlaxoSmithKline, AstraZeneca and seven other companies are inaccurate or misleading.
Brand-name drugmakers use patents to protect their medicines and stave off cheaper, generic medicines. Most blockbuster drugs are protected by dozens of patents covering various ingredients, manufacturing processes and intellectual property. Generic drugmakers can only launch their own cheaper versions if the patents have expired or are successfully challenged in court.
- Previous：US overdose deaths dropped in 2023, the first time since 2018
- Next：Kosovo prepares a new draft law on renting prison cells to Denmark after the first proposal failed
Related articles
- Target to lower prices on basic goods in response to inflation
- World Insights: Bringing China
- Profile: Xi Jinping Leads China on New Journey
- Xi Focus: Xi Calls for Scaling up Global Action on Wetlands Conservation As COP14 Opens
- OpenAI pauses ChatGPT voice after Scarlett Johansson comparisons
- Xi Sends Condolences to S. Korean President over Stampede in Seoul
- Xi Meets Australian PM Albanese
- Xi Arrives in Indonesia's Bali for G20 Summit
- Four people killed in a house explosion in southwestern Missouri
- Xi Meets with CPC National Congress Delegates
- Investigators return to Long Island home of Gilgo Beach serial killing suspect
- City Helps Women Find Jobs Near Home
- Man Who Respects Culture
- CCTF Wins Another Full Score in FTI Report
- Ben Whishaw lights up the Croisette as he joins his co
- Promoting Children's Healthy Growth
- Xi Urges Efforts to Carry Forward Great Founding Spirit of CPC and Yan'an Spirit
- Wenzhou Organizes Family Related Activity
- 'Constantly learning' Imanaga off to impressive start with the Chicago Cubs
- Federation Cultivates 'Legal Docents' to Help Protect Women's Rights
Random recommendation
- Copyright © 2024 Powered by US challenges 'bogus' patents on Ozempic and other drugs in effort to spur competition ,International Index news portal sitemap